Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration (FDA) recently assigned a Prescription Drug User Fee Act (PDUFA) goal date of ...

Taiwan has fully implemented international PIC/S GMP standards to ensure the safety and quality of its medicinal products.

Homegrown fast-food giant Jollibee Foods Corp. (JFC) is expanding its product offerings and consumer base in Taiwan, this ...

The FDA announced draft amendments to Blood Donors’ Health Standards (捐血者健康標準) on Oct. 24 last year, which would raise donor age eligibility to 70 and relax body weight limits, with expectations that ...

MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria (NTM). In recent years, NTM diseases have ...

Access to Apple TV+ would be free in Taiwan from Friday to Sunday as part of a worldwide promotion, Apple Inc said yesterday ...

According to the FTC's decision, the merger would significantly lessen competition in the Taiwan food delivery market, reducing competition that now presses Uber's delivery unit, which is led by Dara ...

Taiwan has blocked Uber Technologies' $950 million purchase of Delivery Hero's Foodpanda business on the island because of concerns it would be anti-competitive, the Fair Trade Commission (FTC ...

Taiwan FTC vice-chairman Chen Chih-min was quoted by the news agency as saying: “In the food delivery platform market, UberEats’ main competitive pressure comes from Foodpanda. The merger would ...

merging the top two players in Taiwan's food delivery market. "If Uber acquires Foodpanda, it will be completely unrestrained by competition," Taiwan's Fair Trade Commission (FTC) vice chairman ...

(RTTNews) - As per media reports, Taiwan has blocked a transaction between Uber and Delivery Hero's Foodpanda business in Taiwan. In May, Uber Technologies (UBER) and Delivery Hero SE reached an ...

belumosudil mesylate), a selective ROCK2 inhibitor for the treatment of chronic graft-versus-host disease (Chronic GVHD), which is currently under application for regulatory approval with the Taiwan ...